PRESS RELEASES

PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary ERYTECH Provides Business and Financial Update for the Third Quarter of 2022
ERYTECH Provides Business and Financial Update for the Third Quarter of 20 2 2 Conference call and webcast on Tuesday, November 22, 2022 at 8:30am ET / 02:30pm CET          Lead program Graspa halted F ocus on preclinical programs and partnering options Deep r estructuring implemented ; team size
View HTML
Toggle Summary ERYTECH Announces Receipt of Nasdaq Notice
ERYTECH Announces Receipt of N asdaq Notice Cambridge, MA (U.S.) and Lyon (France), October 1 3 , 202 2 – ERYTECH Pharma (Nasdaq & Euronext: a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today
View HTML
Toggle Summary Monthly information related to total number of voting rights and shares composing the share capital _September 30, 2022
                 Monthly information related to total number of voting rights and shares composing the share capital _ September 3 0 , 202 2 . Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France Listing markets: Euronext Paris from Euronext (Market segment C
View HTML
Toggle Summary ERYTECH Provides Business and Financial Update for the First Half of 2022
ERYTECH Provides Business and Financial Update for the First Half of 20 2 2 Conference call and webcast on Tuesday, September 13, 2022 at 8:30am ET / 02:30pm CEST          U.S. cell therapy manufacturing facility sold to Catalent in April 2022 Evaluation of partnering options ongoing, strategic
View HTML
Toggle Summary Monthly information related to total number of voting rights and shares composing the share capital _July 31, 2022
                 Monthly information related to total number of voting rights and shares composing the share capital _ Ju ly 3 1 , 202 2 . Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France Listing markets: Euronext Paris from Euronext (Market segment C -
View HTML
Toggle Summary Monthly information related to total number of voting rights and shares composing the share capital _August 31, 2022
                 Monthly information related to total number of voting rights and shares composing the share capital _ August 3 1 , 202 2 . Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France Listing markets: Euronext Paris from Euronext (Market segment C -
View HTML
Toggle Summary ERYTECH Provides Regulatory Update
ERYTECH Provides Regulatory Update ERYTECH to stop further plans to pursue a BLA submission seeking an approval for Graspa ® in hypersensitive ALL Evaluation of strategic partnering options ongoing Cambridge, MA (U.S.) and Lyon (France) , August 2 4 , 202 2 – ERYTECH Pharma (Nasdaq & Euronext:
View HTML
Toggle Summary Monthly information related to total number of voting rights and shares composing the share capital _June 30, 2022.
                 Monthly information related to total number of voting rights and shares composing the share capital _ June 3 0 , 202 2 . Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France Listing markets: Euronext Paris from Euronext (Market segment C -
View HTML
Toggle Summary Report – ERYTECH’s Combined Shareholders’ Meeting On June 24, 2022
REPORT – ERYTECH ’S COMBINED SHAREHOLDERS’ MEETING ON JUNE 2 4 , 20 22 Cambridge, MA (U.S.) and Lyon (France), June 24 , 2022 – ERYTECH Pharma ( Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside
View HTML
Toggle Summary Monthly information related to total number of voting rights and shares composing the share capital _May 31, 2022.
                 Monthly information related to total number of voting rights and shares composing the share capital _May 3 1 , 202 2 . Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France Listing markets: Euronext Paris from Euronext (Market segment C - ISIN
View HTML
Top